Cleared Special

K121950 - MICROTARGETING XL STAR DRIVE SYSTEM

K121950 is an FDA 510(k) clearance for MICROTARGETING XL STAR DRIVE SYSTEM, manufactured by FHC, Inc.. The device is a Class 2 Neurology device with product code HAW cleared through the Special 510(k) pathway after a 23-day FDA review.

K121950 · FHC, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2012
Decision
23d
Days
Class 2
Risk

K121950 is an FDA 510(k) clearance for the MICROTARGETING XL STAR DRIVE SYSTEM. Classified as Neurological Stereotaxic Instrument (product code HAW), Class II - Special Controls.

Submitted by FHC, Inc. (Bowdoin, US). The FDA issued a Cleared decision on July 26, 2012 after a review of 23 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.4560 - the FDA neurology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all FHC, Inc. devices

FDA 510(k) Submission Details - K121950

510(k) Number K121950 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 03, 2012
Decision Date July 26, 2012
Days to Decision 23 days
Submission Type Special
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
125d faster than avg
Panel avg: 148d · This submission: 23d
Pathway characteristics
Modification to existing cleared device.

HAW Device Classification - Class 2, Special Controls

Product Code HAW Neurological Stereotaxic Instrument
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.4560
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - HAW Neurological Stereotaxic Instrument

All 243
Devices cleared under the same product code (HAW) and FDA review panel - the closest regulatory comparables to K121950.
QUADCUT
K130608 · Medtronic Navigation, Inc. · Aug 2013
SYNTHES NAVIGABLE PEDICLE PREPARATION INSTRUMENTS
K122211 · Synthes Spine · Dec 2012
KARL STORZ NAVIGATIONPANEL UNIT (NPU) SYSTEM
K122096 · KARL STORZ Endoscopy-America, Inc. · Sep 2012
SURGICASE GUIDE
K111558 · Materialise NV · Mar 2012
IPLAN
K101627 · Brainlab AG · Jun 2011
DISPOSABLE REFLECTIVE MARKER SPHERES
K100038 · Brainlab AG · Jul 2010